Cerebral small vessel disease research and family advocacy
Building a clear path from inherited small vessel disease to targeted treatment.
CSVD Therapeutics brings families, clinicians, scientists, and therapy developers together around one urgent goal: accelerating credible treatments for genetic cerebral small vessel diseases while keeping patients at the center of the work.
A platform for CSVD families, clinicians, and scientists working toward gene-targeted therapies.
CSVD Therapeutics focuses on inherited forms of CSVD (cerebral small vessel diseases), especially COL4A1-related and NOTCH3-related disorders (CADASIL), where genetics gives us a precise starting point for therapeutic development.
Start with the leadership team, the COL4A1 and CADASIL projects, or the therapeutic development pathway for research readiness.
Who we are
A home for CSVD families and the researchers working beside them.
CSVD Therapeutics is a patient-led research and education platform focused on practical progress: better data, better models, better trial readiness, and a serious exploration of gene-targeted approaches for NOTCH3 and COL4A1-related diseases.
The work is designed around collaboration: families who understand the lived reality of CSVD, clinicians who see the disease course, and scientists developing the tools that could change it.
Our purpose
Turning urgency into organized scientific momentum.
CSVD Therapeutics brings together patient advocacy, translational neuroscience, and cerebrovascular research to help move CSVD toward credible therapeutic progress.
